Researchers aim to determine if rapamycin can be used to treat preclinical dilated cardiomyopathy, the second most-common acquired cardiac disease in dogs.
The easy-to-use, cost-effective tool, which will be offered through the Texas A&M Gastrointestinal Lab, represents a significant development in veterinary medicine.
Although Texas A&M veterinary cardiologist Dr. Ashley Saunders regularly implants canine pacemakers, she recently found herself confronted by multiple challenges as she worked through the night to save a dog's life.
